WINNIPEG, MANITOBA--(MARKET WIRE)--Jul 30, 2007 -- Kane Biotech Inc. (CDNX:KNE.V - News), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce a research publication from the University of Medicine and Dentistry of New Jersey (UMDNJ) on studies using DispersinB(TM) against field isolates of the swine pathogen Actinobacillus pleuropneumoniae. The paper appeared in the recent online edition of the 'Microbial Pathogenesis' journal.
